SANA - Sana Biotechnology - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

967.8M

Cash

349.3M

Avg Qtr Burn

-72.9M

Short % of Float

30.60%

Insider Ownership

11.22%

Institutional Own.

91.09%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
SC291 Details B-cell malignancies	Phase 1 Interim update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.